Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Xpect Vision Raises $21 Million for Photon-Counting X-Ray Imaging Devices

publication date: Jul 21, 2020

Xpect Vision Technology closed a $21 million Series B+ financing round to support its photon-counting X-ray imaging products intended for healthcare and industrial uses. The company applies its photon-counting technology to two products: Xcellent Vision® Mammography, which includes AI-directed analysis, and LinearVision™ for an affordable dental imaging system. Based in Shenzhen, Xpect has R&D centers in Beijing and Shanghai. The round was led by Beijing Jianxing Medical Health Investment, a sub-fund of state-owned CCB International. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital